RioCan Real Estate Investment Trust (TSE:REI.UN) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of RioCan Real Estate Investment Trust (TSE:REI.UN) have received a consensus recommendation of “Moderate Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is C$20.61.

Separately, BMO Capital Markets raised their price objective on shares of RioCan Real Estate Investment Trust from C$20.00 to C$21.00 in a report on Wednesday, November 19th.

RioCan Real Estate Investment Trust Stock Performance

Shares of REI.UN opened at C$19.79 on Wednesday. The firm has a market capitalization of C$5.84 billion, a P/E ratio of 89.95 and a beta of 1.05. The company has a debt-to-equity ratio of 95.37, a current ratio of 0.30 and a quick ratio of 0.08. The business has a fifty day moving average of C$19.09 and a 200 day moving average of C$18.78. RioCan Real Estate Investment Trust has a one year low of C$15.46 and a one year high of C$20.23.

RioCan Real Estate Investment Trust (TSE:REI.UN) last released its quarterly earnings results on Thursday, November 6th. The real estate investment trust reported C($0.41) earnings per share (EPS) for the quarter. RioCan Real Estate Investment Trust had a net margin of 4.86% and a return on equity of 0.78%. The firm had revenue of C$371.17 million for the quarter.

About RioCan Real Estate Investment Trust

Riocan Real Estate Investment Trust is a Canadian real estate investment trust which owns, develops, and operates Canada’s portfolio of retail-focused, increasingly mixed-use properties. The REIT’s property portfolio includes shopping centers and mixed-use developments, with most of its properties located in Ontario, Canada. Riocan’s tenants consist of grocery stores, supermarkets, restaurants, cinemas, pharmacies, and corporates. By geography, the company operates in Canada, which generates the majority of total revenue, and in the United States.